- Spruce Biosciences Recognized as a Bay Area Best Place to Work
- Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
- Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
- Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
- Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
- Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
- Spruce Biosciences to Participate in May Investor Conferences
- Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
- Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
More ▼
Key statistics
On Friday, Spruce Biosciences Inc (SPRB:NSQ) closed at 0.6497, 2.35% above its 52-week low of 0.6348, set on Jun 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.6723 |
---|---|
High | 0.6723 |
Low | 0.6348 |
Bid | 0.64 |
Offer | 0.6412 |
Previous close | 0.6721 |
Average volume | 537.17k |
---|---|
Shares outstanding | 41.15m |
Free float | 37.96m |
P/E (TTM) | -- |
Market cap | 26.74m USD |
EPS (TTM) | -1.15 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 21:00 BST.
More ▼